SHA:688062 Revenue

In the year 2025, Mabwell (Shanghai) Bioscience had annual revenue of 662.52M CNY with 231.62% growth. Mabwell (Shanghai) Bioscience had revenue of 96.68M in the quarter ending December 31, 2025, with 64.74% growth.

Revenue

662.52M

Revenue Growth

+231.62%

P/S Ratio

22.82

Revenue / Employee

500.01K

Employees

1,325

Market Cap

15.12B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	662.52M	462.73M	231.62%
Dec 31, 2024	199.78M	71.95M	56.28%
Dec 31, 2023	127.84M	100.11M	361.03%
Dec 31, 2022	27.73M	11.50M	70.88%
Dec 31, 2021	16.23M	10.92M	206.03%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chengzhi	10.87B
Jinyu Bio-technology	1.33B
Anhui Anke Biotechnology (Group)	2.56B
Inner Mongolia Furui Medical Science	1.60B
Sinocelltech Group	1.56B
InventisBio	37.29M
Staidson (Beijing) BioPharmaceuticals	244.37M
Tibet Cheezheng Tibetan Medicine	2.42B

Revenue Rankings